Komori
Earnings presentation2934J Frontier Co.,Ltd.Food

Publication of the transcript of the briefing on second-quarter results for the fiscal year ending May 2026

The company published a transcript of its briefing on second-quarter results for the fiscal year ending May 2026. As advertising investment was strengthened, progress toward the full-year revenue and EBITDA plans was limited, while the company pursued the acquisition of new subscription customers and various service initiatives to generate revenue in the second half and thereafter.

Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
106.75
億円（第2四半期売上高）
Wording
Conditional
How definitive the wording is.

Contents of this document

Earnings briefing transcript2026年5月期 第2四半期6 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥106.75 hundred million
Operating profitLoss-making
Ordinary incomeLoss-making
Net incomeLoss-making
Full-year earnings forecast
Net Sales
¥236 hundred million
EBITDA
¥10.15 hundred million
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Consolidated
Net Sales45.2%
EBITDA16.2%
Medical Care Sales business
Net Sales44.3%
EBITDA17.1%
Healthcare Sales business
Net Sales40.3%
EBITDA21.0%
Healthcare Marketing business
Net Sales48.9%
EBITDA32.7%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
進捗は限定的
Key points of the Q&AKey questions raised by investors at the briefing and the company's answers
  1. 赤字要因広告投資の強化により第2四半期は赤字となったが、第3四半期以降で投資回収を図ると回答。
  2. KPI改善要因ROI重視の顧客獲得戦略と広告投資の強化により、QAUとARRが好調に推移したと説明。
  3. 計画値変更現時点で具体的には回答できず、業績に影響があれば速やかに開示すると回答。
  4. SOKUYAKUの取り組みSEO、提携、共同キャンペーン、訪日外国人向け施策を説明。
  5. SOKUYAKUベネフィット業種・地域を問わず導入企業が増加しており、営業体制を強化すると説明。
New initiatives
  • SOKUYAKUとVポイントの連携開始
  • 病院・クリニック公式ホームページとのAPI連携予約機能の無料提供
  • 予約不要のオンライン診療機能『今すぐ診療』のリリース
  • 神奈川県中井町の防災訓練でのオンライン診療デモ
  • ダイヤル・サービスとの連携
  • 静岡ジェードとのパートナーシップ契約
  • 障がい者就労事業所へのSOKUYAKU・抗原検査キットの優先提供
  • Rosiのオンライン診療経由での提供
  • 大柴胡湯錠SPの新発売
  • 完全ドリンク酵水素328選もぎたて生スムージーの新発売
  • LILAYオーバルシャンプーブラシの新発売
  • ファブールのクリスマスコフレ数量限定発売
Key KPIsA metric the company considers important as a management benchmark.
  • QAU（四半期のアクティブユーザー）On track
  • ARR (annual recurring revenue)On track
  • Vポイント利用者数1.58 100 million people
  • Vポイント提携先店舗数16 10,000 stores
  • Visa加盟店数1 億店舗
Segment results
Medical Care Sales business
Net Sales
¥25.88 hundred million
EBITDA
¥1.3 hundred million
Healthcare Sales business
Net Sales
¥27.59 hundred million
EBITDA
¥1.01 hundred million
Healthcare Marketing business
Net Sales
¥53.27 hundred million
EBITDA
¥1.43 hundred million
Medium-term management plan targets
薬局・病院との提携伸長目標として記載
Population coverage100%
Contents of this document
ItemDetails
Document typeEarnings briefing transcript
Fiscal Period Covered2026年5月期 第2四半期
Net Sales¥106.75 hundred million
Operating profitLoss-making
Ordinary incomeLoss-making
Net incomeLoss-making
Full-year earnings forecastNet Sales ¥236 hundred million / EBITDA ¥10.15 hundred million
Progress against full-year forecastConsolidated Net Sales 45.2% / EBITDA 16.2% / Medical Care Sales business Net Sales 44.3% / EBITDA 17.1% / Healthcare Sales business Net Sales 40.3% / EBITDA 21.0% / Healthcare Marketing business Net Sales 48.9% / EBITDA 32.7%
Self-assessment against the plan進捗は限定的
Segment resultsMedical Care Sales business Net Sales ¥25.88 hundred million / EBITDA ¥1.3 hundred million / Healthcare Sales business Net Sales ¥27.59 hundred million / EBITDA ¥1.01 hundred million / Healthcare Marketing business Net Sales ¥53.27 hundred million / EBITDA ¥1.43 hundred million
Key KPIsIndicator name QAU（四半期のアクティブユーザー） / Value On track / Year on year against the same period last year Not disclosed, Indicator name ARR (annual recurring revenue) / Value On track / Year on year against the same period last year Not disclosed, Indicator name Vポイント利用者数 / Value 1.58 100 million people / Year on year against the same period last year Not disclosed, Indicator name Vポイント提携先店舗数 / Value 16 10,000 stores / Year on year against the same period last year Not disclosed, Indicator name Visa加盟店数 / Value 1 億店舗 / Year on year against the same period last year Not disclosed
Medium-term management plan targets薬局・病院との提携伸長 目標として記載 / Population coverage 100%
Key points of the Q&A赤字要因：広告投資の強化により第2四半期は赤字となったが、第3四半期以降で投資回収を図ると回答。, KPI改善要因：ROI重視の顧客獲得戦略と広告投資の強化により、QAUとARRが好調に推移したと説明。, 計画値変更：現時点で具体的には回答できず、業績に影響があれば速やかに開示すると回答。, SOKUYAKUの取り組み：SEO、提携、共同キャンペーン、訪日外国人向け施策を説明。, SOKUYAKUベネフィット：業種・地域を問わず導入企業が増加しており、営業体制を強化すると説明。
New initiativesSOKUYAKUとVポイントの連携開始, 病院・クリニック公式ホームページとのAPI連携予約機能の無料提供, 予約不要のオンライン診療機能『今すぐ診療』のリリース, 神奈川県中井町の防災訓練でのオンライン診療デモ, ダイヤル・サービスとの連携, 静岡ジェードとのパートナーシップ契約, 障がい者就労事業所へのSOKUYAKU・抗原検査キットの優先提供, Rosiのオンライン診療経由での提供, 大柴胡湯錠SPの新発売, 完全ドリンク酵水素328選もぎたて生スムージーの新発売, LILAYオーバルシャンプーブラシの新発売, ファブールのクリスマスコフレ数量限定発売
Items this document does not state (17)
Gross Profit MarginOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / Share

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

下期以降の売上高に寄与する新規定期顧客の獲得を目的に広告投資を強化したため、売上高およびEBITDAの通期計画に対する進捗が限定的となった。会社は、投資回収には一定期間を要するビジネスモデルであり、第3四半期以降で投資回収を図るとしている。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Publication of the transcript of the briefing on second-quarter results for the fiscal year ending May 2026 | J Frontier Co.,Ltd. (2934) timely disclosure | Komori